Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.

Annals of clinical biochemistry - 1 Jan 2003

Verbeek M M, De Jong D, Kremer H P H

Abstract excerpt

Neurodegenerative disorders have traditionally been classified according to clinical criteria, e.g. as dementia syndromes (the best known is Alzheimer's disease) or as movement disorders (e.g. Parkinson's disease). Another subdivision is based on recent insights into the respective pathogenetic mechanisms, leading to the recognition of so-called tauopathies and alpha-synucleinopathies. It is this increased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Creutzfeldt-Jakob Syndrome
Share to Glial Fibrillary Acidic Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nerve Growth Factors

Share to Neurofilament Proteins

Share to Phosphopyruvate Hydratase

Share to S100 Calcium Binding Protein beta Subunit

Share to S100 Proteins

Share to Synucleins

Source

Identifiers

PMID: 12542908
DOI: 10.1258/000456303321016141

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.PMID 12542908Read ↗

Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseasesSemantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

The Use of Proteomics in Biomarker Discovery in Neurodegenerative DiseasesSemantic proximity Read ↗

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Semantic proximity Read ↗

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an updateSemantic proximity Read ↗

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity Read ↗

Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia.Semantic proximity Read ↗

Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease.Semantic proximity Read ↗

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: The Present and the FutureSemantic proximity Read ↗

Blood-Based Protein Biomarkers for Diagnosis and Classification of Neurodegenerative DiseasesSemantic proximity Read ↗

Cerebrospinal fluid biomarker for Parkinson's disease: An overviewSemantic proximity Read ↗

Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.